Table 2.
Concomitant medications group | Treatment arm | Probability of an event (95% CI) by Week 52, % | Hazard ratio (95% CI) |
---|---|---|---|
Steroids only | Placebo (n = 61) | 78.1 (67.0, 87.6) | 0.64 (0.42, 0.96) |
Belimumab 10 mg/kg (n = 78) | 64.3 (53.6, 74.9) | ||
AM only | Placebo (n = 32) | 84.4 (70.0, 94.3) | 0.82 (0.48, 1.38) |
Belimumab 10 mg/kg (n = 45) | 81.6 (68.3, 91.8) | ||
Steroids + AM | Placebo (n = 186) | 80.3 (74.2, 85.8) | 0.83 (0.65, 1.06) |
Belimumab 10 mg/kg (n = 160) | 71.2 (63.9, 78.2) | ||
Steroids + AM + IS | Placebo (n = 139) | 87.9 (81.7, 92.7) | 0.81 (0.62, 1.05) |
Belimumab 10 mg/kg (n = 133) | 82.3 (75.3, 88.3) |
AM: antimalarial; CI: confidence interval; IS: immunosuppressant.